Global Hemp Group, Inc. engages in the development of hemp cultivation for cannabinoid extraction. The company is headquartered in North Vancouver, British Columbia. The company went IPO on 2010-04-14. The firm is focused on two business segments: Industrial Hemp and Health & Wellness (Biopharma). The Industrial Hemp segment primary focus lies in the environmental uses of hemp for construction and hemp for sustainable bio-energy sources, both contributing to a carbon-negative footprint. The company is also focused on aligning with its hemp agro-industrial zone (HAIZ) strategy to achieve a carbon-negative footprint. Its principal feature of the HAIZ concept is the proximity of the industrial plant to the supply of raw materials and final markets. The Health and Wellness segment is focused on the acquisition of exclusive licensing of patents and intellectual property (IP). The company acquired exclusive rights to key patents and IP of Apollon Formularies plc., a UK-based international pharmaceutical company whose formulations and patents specialize in developing cancer treatments from natural biologics, including cannabinoids and functional mushrooms.
Follow-Up Questions
¿Cuál es el ratio P/E de Global Hemp Group Inc (GBHPF)?
El ratio P/E de Global Hemp Group Inc es N/A
¿Qué tal es el rendimiento del precio de la acción GBHPF?
El precio actual de GBHPF es de 0.01, ha decreased un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Global Hemp Group Inc?
Global Hemp Group Inc pertenece a la industria Food Products y el sector es Consumer Staples
¿Cuál es la capitalización bursátil de Global Hemp Group Inc?
La capitalización bursátil actual de Global Hemp Group Inc es $348.8
¿Es Global Hemp Group Inc una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 0 analistas han realizado calificaciones de análisis para Global Hemp Group Inc, incluyendo 0 fuerte compra, 0 compra, 0 mantener, 0 venta, y 0 fuerte venta
